Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 499 across all filing types
Latest filing 2024-10-18 Director's Dealing
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Orphazyme aktier
Director's Dealing Classification · 100% confidence The document title 'Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Orphazyme aktier' translates to 'Transactions by board members, directors, or closely related persons in Orphazyme shares'. The content explicitly lists notifications of transactions by insiders. This falls directly under the definition of Director's Dealing (DIRS).
2024-10-18 Danish
Director's Dealing 2024
Director's Dealing Classification · 98% confidence The document is titled "Selskabsmeddelelse 30/2024" (Company Announcement 30/2024) from Orphazyme A/S. The subject line explicitly states: "Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Orphazyme aktier" (Trading in Orphazyme shares by members of the Board of Directors, executive management, or closely related persons). This directly corresponds to the definition of Director's Dealing. The text concludes with "Se venligst vedlagte" (Please see attached), indicating the details are in an attachment, but the core subject matter is insider trading notification, which maps to the DIRS code.
2024-10-11 Danish
Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Orphazyme aktier
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions conducted by persons discharging managerial responsibilities (PDMRs) and their closely associated persons, as required by the EU Market Abuse Regulation (MAR). It details the name of the entity (Nordic Compound Invest A/S), the issuer (Orphazyme A/S), the nature of the transaction (purchase of shares), the price, quantity, and date. This fits the definition of a Director's Dealing (DIRS) report.
2024-10-11 Danish
Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Orphazyme aktier
Director's Dealing Classification · 100% confidence The document title 'Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Orphazyme aktier' translates to 'Transactions by board members, directors, or closely related persons with Orphazyme shares'. This is a standard notification for insider trading or director dealings. The document is short and points to attached files containing the specific transaction details, which aligns with the definition for Director's Dealing (DIRS).
2024-10-11 Danish
Director's Dealing 2024
Director's Dealing Classification · 99% confidence The document is very short (492 characters) and is titled 'Selskabsmeddelelse 29/2024' (Company Announcement 29/2024). The content explicitly states 'Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Orphazyme aktier' (Trading in Orphazyme shares by members of the Board of Directors, executive management, or closely related persons) and concludes with 'Se venligst vedlagte' (Please see attached). This structure—a brief announcement referencing an attachment detailing insider trading—strongly suggests a Director's Dealing report. The corresponding code is DIRS.
2024-10-07 Danish
Bestyrelsesmedlemmers direktørers eller nærtstående personers handel med Orphazyme aktier._
Director's Dealing Classification · 100% confidence The document is a standard regulatory form (Skema) used for reporting transactions by persons discharging managerial responsibilities (PDMRs) and their closely associated persons, as required by market abuse regulations (MAR). It explicitly details the purchase of shares by a person with managerial responsibility (the Chairman) in Orphazyme A/S. This falls under the category of Director's Dealing.
2024-10-07 Danish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.